Advertisement

Topics

Latest "Global Chinese Methylated melamine formaldehyde resin Industry 2017" News Stories

02:18 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Global Chinese Methylated melamine formaldehyde resin Industry 2017" found in our extensive news archives from over 250 global news sources.

More Information about Global Chinese Methylated melamine formaldehyde resin Industry 2017 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Chinese Methylated melamine formaldehyde resin Industry 2017 for you to read. Along with our medical data and news we also list Global Chinese Methylated melamine formaldehyde resin Industry 2017 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Chinese Methylated melamine formaldehyde resin Industry 2017 Companies for you to search.

Showing "Global Chinese Methylated melamine formaldehyde resin Industry 2017" News Articles 1–25 of 26,000+

Friday 22nd March 2019

Polybutylene Terephthalate PBT Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Polybutylene Terephthalate PBT report provides an independent information about the Polybutylene Terephthalate PBT industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview an...


The effect of the Chinese Famine on type 2 diabetes mellitus epidemics

Xiangxue Approved to Start China Trial of T-Cell Therapy for Solid Tumors

Guangzhou Xiangxue Life Sciences (XLifeSc), a subsidiary of Xiangxue Pharmaceutical, was approved by China's NMPA to start clinical studies of its T-cell receptor Affinity Enhanced Specific T-cell (TAEST) therapy in patients with solid tumors. Earlier, XLifeSc announced positive results from a small pilot study of the TAEST thrapy in China. Xiangxue in-licensed the therapy from Athenex, a New York...


I-Mab Starts Greater China Trials of CD38 Antibody for Myeloma

I-Mab Biopharma, a Shanghai company focused on immuno-oncology and autoimmune diseases, dosed the first patient in a Phase II Taiwan trial of a CD38 antibody in patients with relapsed or refractory multiple myeloma. In 2017, I-Mab acquired greater China rights to TJ202/MOR202 from MorphoSys AG in a $120 million deal. The multi-center trial, which will also include mainland China sites, is designed...

Printed Electronics Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Printed Electronics report provides an independent information about the Printed Electronics industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.T...

Thursday 21st March 2019

Global Food Retail Market Research Report 20122024 [Report Updated: 01011970] Prices from USD $1800

The global Food Retail market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major product...

BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease

STOCKHOLM, Sweden, March 21, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that its partner Eisai has initiated the global Phase 3 confirmatory study of BAN24...

$12m boost for Australian space sector

The Australian Government has announced $12 million in funding to strengthen the nation’s space sector, consisting of $6 million towards a Mission Control Centre and $6 million to establish a Space Discovery Centre. Both will be based in Adelaide, the home of the Australian Space Agency, and are being built with the support of and in collaboration with the South Australian Government. Minister...

To Abort or Not to Abort–Making Difficult Choices Alone

(Eurekalert) – Almost half of all pregnancies are unplanned. In 2017, 12 733 abortions were carried out in Norway. The number of live births the same year was 56 600. In her doctoral work at the Norwegian University of Science … Read More

Generic Industry Market Forces May Impact GDUFA III Talks

AAM's Chip Davis said a user fee cut is not in order, but industry consolidation and product launch problems may...    

CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)

SUZHOU, China, March 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that China's National Medical Products Administration (NMPA) has approved the clinical trial application to begin a Phase 1 trial in China for BLU-667 (CS3009), a highly selective and potent RET inhibitor discovered by CStone's partner Blueprint Medicines. The study is part of Blue...

CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

LAS VEGAS, March 21, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating brand, PlusCBD Oil™, announced today the appointment of … Continue reading →

IMV Inc. Announces 2018 Year-end Financial and Operational Results and Provides Updates on Key Clinical Programs

Attained multiple milestones in DECIDE1/2 clinical program in advanced ovarian cancer Achieved initial positive data from phase 2 clinical trial in DLBCL with Merck Initiated a phase 2 basket trial across five indications under a collaboration with Merck Listed on Nasdaq and changed Corpora...

Part D Rebates: Policy Tweak Would Retain Manufacturer ‘Contributions’

Peter Bach’s new approach to calculating TrOOP cost in Medicare would prevent big savings to manufacturers from point-of-sale rebates.   

Novanta to Present at Needham & Company 18th Annual Healthcare Conference on Tuesday, April 9, 2019

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the Needham & Company 18th Annual Healthcare Conference on Tuesday, April 9, 2019, in New York, NY. About Novant...

Antidote Technologies’ Laurent Schockmel Recognized as a Top 40 Healthcare Transformer

Schockmel will join honor roll of visionaries working to effect much-needed change in the healthcare industry NEW YORK (PRWEB) March 21, 2019 Laurent Schockmel, CEO, Antidote Technologies, has been named a top 40 Healthcare Transformer by Medical Marketing & Media (MM&M). This honor is given to those driving innovation at the intersection of healthcare and technology. The influential fina...

China regions see birthrates decline in 2018: China Daily

Several Chinese regions, including the capital Beijing, saw birthrates decline again in 2018, the official China Daily reported, after a 2016 move to relax family planning controls failed to encourage couples to have more children.

ESO Enters into Exclusive Partnership with NarcBox to Help Agencies and Departments Manage Narcotic Distribution and Tracking

Emerging Drug Enforcement Administration (DEA) rule changes related to the transport and dispensing of controlled substances will have a major impact in the industry ESO, the leading data and software company serving emergency medical services (EMS), fire departments and hospitals, today announced it has entered into an exclusive partnership wit...

Nat Geo WILD Taps Emmy Award-Winning Mark Steines as Host of Animal ER Live, a New Live Event Series from Big Fish Entertainment

From the Creators of “Live PD,” Animal ER Live Puts Viewers a Heartbeat Away From the Doctors Saving Our Pets in Cities Across the Country, From Vet ERs in Boston, Massachusetts; Portland, Oregon; Charleston, South Carolina; Plainfield, Illinois; Kanab, Utah; Fort Bragg, California; and Waller, Texas. Anchored in a Studio in New York City, Ste...

ESO and Praetorian Digital Announce Partnership to Integrate Real-Time Data and Online Training to Improve First Responder Performance through Predictive Learning

Partnership integrates FireRescue1 Academy and EMS1 Academy with ESO’s suite of products ESO, the leading data and software company serving emergency medical services (EMS), fire departments and hospitals, and

Tekla Healthcare Investors Announce Renewal of Share Repurchase Program

Tekla Healthcare Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2019. The renewal will allow the Fund to purchase in the ...

Surgical Headlights Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Surgical Headlights report provides an independent information about the Surgical Headlights industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.T...

Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials

HANGZHOU, China, March 21, 2019 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye"), a global clinical-stage biopharmaceutical company today announced that it has received a clearance from the National Medical Products Administration (NMPA) of China for initiating the open-label, randomized, multicenter, global phase III clinical trial for pelareorep (AN1004) in combination with pacl...

Healogics® Brings Vein Ablation Services to Wound Care Centers®

Healogics® VeinCare aims to partner with existing practices to provide more comprehensive patient care in the outpatient setting Healogics, the nation’s largest provider of advanced chronic wound care services, today announced they have added vein ablation to their in-house service offerings through a new program called Healogics® VeinCare. This pr...

Crossix Launches DIFA TV™ to Transform TV Analytics for Healthcare Marketers

The industry-leading Crossix DIFA™ Platform now supports TV measurement and optimization Crossix announced today it has launched DIFA TV™, a television advertising measurement platform. Healthcare brands can use DIFA TV to understand how effectively their national TV advertising is reaching a relevant health audience, the health actions that are ta...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks